Ovarian Cancer Risk Factor Associations by Primary Anatomic Site: The Ovarian Cancer Cohort Consortium

Renée Turzanski Fortner & Leo J Schouten et al. · 2020-07-30

Abstract

Background:

Epithelial ovarian, fallopian tube, and primary peritoneal cancers have shared developmental pathways. Few studies have prospectively examined heterogeneity in risk factor associations across these three anatomic sites.

Methods:

We identified 3,738 ovarian, 337 peritoneal, and 176 fallopian tube incident cancer cases in 891,731 women from 15 prospective cohorts in the Ovarian Cancer Cohort Consortium. Associations between 18 putative risk factors and risk of ovarian, peritoneal, and fallopian tube cancer, overall and for serous and high-grade serous tumors, were evaluated using competing risks Cox proportional hazards regression. Heterogeneity was assessed by likelihood ratio tests.

Results:

Most associations did not vary by tumor site (Phet ≥ 0.05). Associations between first pregnancy (Phet = 0.04), tubal ligation (Phet = 0.01), and early-adult (age 18–21 years) body mass index (BMI; Phet = 0.02) and risk differed between ovarian and peritoneal cancers. The association between early-adult BMI and risk further differed between peritoneal and fallopian tube cancer (Phet = 0.03). First pregnancy and tubal ligation were inversely associated with ovarian, but not peritoneal, cancer. Higher early-adult BMI was associated with higher risk of peritoneal, but not ovarian or fallopian tube, cancer. Patterns were generally similar when restricted to serous and high-grade serous cases.

Conclusions:

Ovarian, fallopian tube, and primary peritoneal cancers appear to have both shared and distinct etiologic pathways, although most risk factors appear to have similar associations by anatomic site.

Impact:

Further studies on the mechanisms underlying the differences in risk profiles may provide insights regarding the developmental origins of tumors arising in the peritoneal cavity and inform prevention efforts.

Funding

NCI NIH HHS

UM1 CA164973

NCI NIH HHS

P30 CA016087

Cancer Research UK

C570/A16491

NCI NIH HHS

UM1 CA182934

Medical Research Council

G1000143

NIEHS NIH HHS

P30 ES000260

NCI NIH HHS

R01 CA039742

Medical Research Council

G0401527

NCI NIH HHS

UM1 CA186107

Medical Research Council

MR/M012190/1

Intramural NIH HHS

Z01 CP010126

Intramural NIH HHS

Z01 ES044005

NCI NIH HHS

P01 CA087969

Cancer Research UK

14136

Medical Research Council

MR/N003284/1

NCI NIH HHS

R01 CA067262

Cancer Research UK

C8221/A19170

NCI NIH HHS

UM1 CA176726

NCI NIH HHS

K05 CA154337

Medical Research Council

1000143

NIMHD NIH HHS

U54 MD007601

World Health Organization

001

NCI NIH HHS

U01 CA164973

Centers for Disease Control and Prevention

NU58DP006333

Department of Defense Ovarian Cancer Research

W81XWH-12-1-0561

NCI Office of Dietary Supplements

K05 CA154337

Iowa Women's Health Study

R01 CA39742

Nurses' Health Study

R01 CA39742

Nurses' Health Study

UM1 CA186107

Nurses' Health Study

P01 CA87969

Nurses' Health Study

UM1 CA176726

Nurses' Health Study

R01 CA67262

NIH

UM1 CA182934

NYU Women's Health Study

P30 CA016087

NYU Women's Health Study

P30 ES000260

NCI Intramural Research Program National Institute of Environmental Health Sciences

Z01-ES044005

Health Research Fund

PI13/00061

Health Research Fund

PI13/01162

ISCIII

RD06/0020

Australian National Health Medical Research Council Cancer Council Victoria

209057

Australian National Health Medical Research Council Cancer Council Victoria

396414

Australian National Health Medical Research Council Cancer Council Victoria

1074383